 BioSpecifics Technologies Corp. NASDAQ:BSTC has been given an average broker rating score of 1.00 Strong Buy from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation. Analysts have set a 12 month consensus price target of 90.00 for the ... 